- Delivering Pan India
Stelara® (Ustekinumab) Ustekinumab 45 mg and 90 mg injection, 130 mg IV vial by Janssen (Johnson & Johnson). Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Ustekinumab 45 mg, 90 mg, 130 mg |
|---|---|
| Manufacturer | Janssen (Johnson & Johnson) |
| Country | Belgium |
| Pack size | 1 prefilled syringe or 1 vial |
| Storage | Store refrigerated at 2°C to 8°C in the original carton, as stated on the label |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Stelara® (Ustekinumab) 45 mg, 90 mg Injection and 130 mg IV Vial: A Sourcing Guide for Hospitals and Pharmacies
Stelara® is an ustekinumab injection (interleukin-12 and -23 antagonist) marketed by Janssen, a Johnson & Johnson company. The decision to prescribe ustekinumab, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Stelara® (ustekinumab) 45 mg and 90 mg injection and 130 mg intravenous vial to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the Immunosuppressant category. Supply is in bulk/wholesale quantities only.
Stelara contains ustekinumab, a human monoclonal antibody. The US label lists 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringes for subcutaneous use and a 130 mg/26 mL single-dose vial for intravenous use. Presentations marketed in India are those on the Indian pack.
How it works, according to the label: The US prescribing information (DailyMed) describes ustekinumab as a human interleukin-12 and -23 antagonist that binds the p40 protein subunit shared by both cytokines.
The current US prescribing information for Stelara (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Stelara pack insert.
Published studies of ustekinumab include PHOENIX 1 and PHOENIX 2 (Lancet 2008) in plaque psoriasis, UNITI-1 and UNITI-2 with IM-UNITI (N Engl J Med 2016) in Crohn’s disease and UNIFI (N Engl J Med 2019) in ulcerative colitis. Results and conclusions are those of the trial authors and the prescribing information; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack (confirm against the carton) |
|---|---|---|
| Ustekinumab 45 mg/0.5 mL | Solution for subcutaneous injection | Prefilled syringe (confirm against the carton) |
| Ustekinumab 90 mg/mL | Solution for subcutaneous injection | Prefilled syringe (confirm against the carton) |
| Ustekinumab 130 mg/26 mL | Solution for intravenous infusion | Single-dose vial (confirm against the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, dermatology, rheumatology and gastroenterology centres, infusion centres and pharmacies in India that need to source Stelara in bulk quantities from a licensed distributor.
Side effects are listed in the prescribing information and Indian pack insert and are not summarised here. Refer to the label and consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Store refrigerated at 2°C to 8°C in the original carton, protected from light, as directed on the pack. Do not freeze or shake.
Stelara is marketed by Janssen, a Johnson & Johnson company. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Stelara through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Stelara available in India?
A.K. Pharma supplies Stelara® (ustekinumab) 45 mg and 90 mg injection and 130 mg intravenous vial to hospitals and pharmacies in India. Contact us for current availability.
What does Stelara contain?
Stelara contains ustekinumab, marketed by Janssen (Johnson & Johnson). The details of use are those on its label.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Stelara be stored?
The label directs refrigerated storage at 2°C to 8°C in the original carton. Check the carton for the exact instructions.
Which Stelara strengths does A.K. Pharma supply?
Contact us for current availability of the 45 mg, 90 mg and 130 mg presentations.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
